Armata Pharmaceuticals (ARMP) Operating Expenses (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Operating Expenses of $9.6 million for Q1 2026, down 35.78% sequentially from $14.9 million in Q4 2025, and up 10.27% YoY from $8.7 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Operating Expenses (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Operating Expenses for 14 years, with the latest figure at $9.6 million in Q1 2026.
- Quarterly Operating Expenses rose 10.27% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.4 million (down 5.92% YoY) and the FY2025 annual result came in at $41.5 million, down 12.75% from the prior year.
- Operating Expenses fell to $9.6 million in Q1 2026 per ARMP's latest filing, from $14.9 million in the prior quarter.
- Over five years, Operating Expenses peaked at $14.9 million in Q4 2025 and troughed at $8.7 million in Q1 2025.
- A 5-year average of $11.0 million and a median of $11.1 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses soared 61.7% in 2022, then declined 29.81% in 2025.
- Over 5 years, Operating Expenses stood at $11.4 million in 2022, then decreased by 2.39% to $11.1 million in 2023, then rose by 6.01% to $11.8 million in 2024, then increased by 26.62% to $14.9 million in 2025, then sank by 35.78% to $9.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $9.6 million, $14.9 million, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | 12.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.82 Mn |
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | 14.91 Mn |
| Sep 30, 2025 | 8.94 Mn |
| Jun 30, 2025 | 9.01 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 11.77 Mn |
| Sep 30, 2024 | 12.73 Mn |
| Jun 30, 2024 | 11.91 Mn |
| Mar 31, 2024 | 11.19 Mn |
| Dec 31, 2023 | 11.11 Mn |
| Sep 30, 2023 | 11.56 Mn |
| Jun 30, 2023 | 10.61 Mn |
| Mar 31, 2023 | 12.14 Mn |
| Dec 31, 2022 | 11.38 Mn |
| Sep 30, 2022 | 9.96 Mn |
| Jun 30, 2022 | 11.10 Mn |
| Mar 31, 2022 | 10.01 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Sep 30, 2021 | 7.39 Mn |